CNTA — Centessa Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $6.19bn
- $6.03bn
- $15.00m
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1
Centessa hits record high on up to $7.8 billion Eli Lilly buyout
Deals of the day-Mergers and acquisitions
Centessa Pharma jumps after Eli Lilly agrees to buy co for up to $7.8 billion
Eli Lilly to buy Centessa in $6.3 billion deal for sleep medicines (updated)
Eli Lilly to buy Centessa Pharma in $6.3 billion deal
Appoints Mario Alberto Accardi As CEO
Centessa Pharma rallies after $250 mln share sale
Centessa Pharma drops on $250 mln share sale
Brief: Centessa Pharmaceuticals Announces Pricing Of $250,000,000 Public Offering Of American Depositary Shares
Centessa Pharma slips after launching share offering
Nxera To Receive Us$4.8 Mn In Milestone Payments Following Centessa's Initiation Of Clinical Development Of Orx142, A Novel Ox2r Agonist
Centessa Pharma up after Leerink raises price target
TD Cowen starts coverage of Centessa Pharma with 'buy'
Enters Loan And Security Agreement With Oxford Finance
Centessa Pharma jumps after upsized $225 mln stock offering